Stifel Financial Corp Invests $625,000 in Grail, Inc. (NASDAQ:GRAL)

Stifel Financial Corp bought a new position in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 34,992 shares of the company's stock, valued at approximately $625,000. Stifel Financial Corp owned about 0.10% of Grail as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Crcm LP purchased a new stake in shares of Grail during the fourth quarter valued at approximately $65,061,000. Primecap Management Co. CA purchased a new stake in Grail in the fourth quarter worth $37,118,000. Vanguard Group Inc. bought a new stake in shares of Grail in the fourth quarter valued at $25,902,000. Arbiter Partners Capital Management LLC purchased a new position in shares of Grail during the 4th quarter valued at $14,827,000. Finally, Geode Capital Management LLC bought a new position in shares of Grail during the 4th quarter worth $7,920,000.

Analyst Ratings Changes

A number of brokerages have weighed in on GRAL. Morgan Stanley increased their target price on shares of Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a research report on Tuesday, March 18th. Canaccord Genuity Group boosted their target price on shares of Grail from $32.00 to $43.00 and gave the company a "buy" rating in a report on Wednesday.

Grail Trading Down 3.6%

Shares of Grail stock traded down $1.40 on Friday, reaching $37.59. The stock had a trading volume of 944,423 shares, compared to its average volume of 1,252,546. The business's 50 day moving average is $29.83 and its two-hundred day moving average is $26.38. Grail, Inc. has a 1 year low of $12.33 and a 1 year high of $63.99. The company has a market cap of $1.33 billion and a P/E ratio of -0.62.

Grail (NASDAQ:GRAL - Get Free Report) last released its quarterly earnings results on Tuesday, May 13th. The company reported ($3.10) EPS for the quarter, beating analysts' consensus estimates of ($4.03) by $0.93. The firm had revenue of $31.84 million for the quarter, compared to analysts' expectations of $35.80 million. On average, equities analysts anticipate that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Insider Transactions at Grail

In related news, CEO Robert P. Ragusa sold 94,035 shares of the stock in a transaction dated Friday, May 2nd. The stock was sold at an average price of $33.93, for a total transaction of $3,190,607.55. Following the completion of the sale, the chief executive officer now directly owns 734,627 shares in the company, valued at $24,925,894.11. This represents a 11.35% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, President Joshua J. Ofman sold 2,109 shares of Grail stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.20, for a total transaction of $65,800.80. Following the completion of the transaction, the president now directly owns 559,673 shares in the company, valued at approximately $17,461,797.60. The trade was a 0.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 194,948 shares of company stock valued at $6,583,130 in the last quarter. Insiders own 1.85% of the company's stock.

Grail Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.